High medical costs are inevitable. But they’re also predictable and manageable with the right data. Employers must understand the needs of their employees, in order to anticipate, address and manage high medical costs.

Flu season is almost in full swing, and older adults, and seniors in particular, need to be extra cautious. To make a case for the flu vaccine among Medicare-eligible adults, we scoured the web for stats on some of the dangers that the flu poses for older adults, the complications it can cause, as well as the efficacy and benefits of getting the shot.

Looking for a Medicare Advantage plan? Understanding star ratings – and knowing where to find them – can help you select the plan that's best for you.

Monkeypox, also called MPX, has been making headlines as of late. But, what exactly is Monkeypox? How did it come about, and what does it look like when a person contracts it? We tapped the expertise of Dr. Mark Netoskie, a market medical executive at Cigna, to answer these questions and more.

Biosimilars represent a meaningful opportunity to reduce drug spending by as much as $375 billion over the next decade. Cigna is committed to driving greater value and lower costs where clinically appropriate for our customers and clients. As a longtime advocate for greater availability of biosimilars, we have worked for a decade to advance the pathways needed to bring biosimilars to market.